Benjamin R Yerxa - Net Worth and Insider Trading

Benjamin R Yerxa Net Worth

The estimated net worth of Benjamin R Yerxa is at least $21,548 dollars as of 2024-06-10. Benjamin R Yerxa is the Director of Clearside Biomedical Inc and owns about 17,957 shares of Clearside Biomedical Inc (CLSD) stock worth over $21,548. Details can be seen in Benjamin R Yerxa's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Benjamin R Yerxa has not made any transactions after 2024-05-15 and currently still holds the listed stock(s).

Transaction Summary of Benjamin R Yerxa

To

Benjamin R Yerxa Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Benjamin R Yerxa owns 1 companies in total, including Clearside Biomedical Inc (CLSD) .

Click here to see the complete history of Benjamin R Yerxa’s form 4 insider trades.

Insider Ownership Summary of Benjamin R Yerxa

Ticker Comapny Transaction Date Type of Owner
CLSD Clearside Biomedical Inc 2024-05-15 director

Benjamin R Yerxa Latest Holdings Summary

Benjamin R Yerxa currently owns a total of 1 stock. Benjamin R Yerxa owns 17,957 shares of Clearside Biomedical Inc (CLSD) as of May 15, 2024, with a value of $21,548.

Latest Holdings of Benjamin R Yerxa

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CLSD Clearside Biomedical Inc 2024-05-15 17,957 1.20 21,548

Holding Weightings of Benjamin R Yerxa


Benjamin R Yerxa Form 4 Trading Tracker

According to the SEC Form 4 filings, Benjamin R Yerxa has made a total of 1 transactions in Clearside Biomedical Inc (CLSD) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Clearside Biomedical Inc is the acquisition of 7,813 shares on May 15, 2024, which cost Benjamin R Yerxa around $10,235.

Insider Trading History of Benjamin R Yerxa

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Benjamin R Yerxa Trading Performance

GuruFocus tracks the stock performance after each of Benjamin R Yerxa's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Benjamin R Yerxa is %. GuruFocus also compares Benjamin R Yerxa's trading performance to market benchmark return within the same time period. The performance of stocks bought by Benjamin R Yerxa within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Benjamin R Yerxa's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Benjamin R Yerxa

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -7.58 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -8.31 LIMIT LIMIT LIMIT LIMIT LIMIT

Benjamin R Yerxa Ownership Network

Ownership Network List of Benjamin R Yerxa

No Data

Ownership Network Relation of Benjamin R Yerxa

Insider Network Chart

Benjamin R Yerxa Owned Company Details

What does Clearside Biomedical Inc do?

Who are the key executives at Clearside Biomedical Inc?

Benjamin R Yerxa is the director of Clearside Biomedical Inc. Other key executives at Clearside Biomedical Inc include 10 percent owner Bradford T Whitmore , Chief Financial Officer Charles A. Deignan , and director & 10 percent owner Clay Thorp .

Clearside Biomedical Inc (CLSD) Insider Trades Summary

Over the past 18 months, Benjamin R Yerxa made 1 insider transaction in Clearside Biomedical Inc (CLSD) with a net purchase of 7,813. Other recent insider transactions involving Clearside Biomedical Inc (CLSD) include a net purchase of 580,222 shares made by Bradford T Whitmore , a net sale of 38,030 shares made by George M Lasezkay , and a net sale of 26,930 shares made by Charles A. Deignan .

In summary, during the past 3 months, insiders sold 0 shares of Clearside Biomedical Inc (CLSD) in total and bought 137,813 shares, with a net purchase of 137,813 shares. During the past 18 months, 80,830 shares of Clearside Biomedical Inc (CLSD) were sold and 752,035 shares were bought by its insiders, resulting in a net purchase of 671,205 shares.

Clearside Biomedical Inc (CLSD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Clearside Biomedical Inc Insider Transactions

No Available Data

Benjamin R Yerxa Mailing Address

Above is the net worth, insider trading, and ownership report for Benjamin R Yerxa. You might contact Benjamin R Yerxa via mailing address: Inspire Pharmaceuticals, Inc.,, 4222 Emperor Blvd., Ste. 470, Durham Nc 27703-8466.

Discussions on Benjamin R Yerxa

No discussions yet.